Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal?
04:00pm, Thursday, 24'th Apr 2025
Tempus AI TEM has skyrocketed 21% in the last three days, fueled by news of a $200 million partnership with AstraZeneca AZN and Pathos AI. The multi-year deal focuses on building a multimodal AI-drive
Unveiling Astrazeneca (AZN) Q1 Outlook: Wall Street Estimates for Key Metrics
10:20am, Thursday, 24'th Apr 2025
Get a deeper insight into the potential performance of Astrazeneca (AZN) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for s
Tempus AI shares jump on new oncology AI partnerships with AstraZeneca, Pathos
11:41am, Wednesday, 23'rd Apr 2025
Tempus AI (NASDAQ:TEM) said on Wednesday it has signed multi-year strategic collaborations with AstraZeneca (AZN.L) and Pathos AI to co-develop what it called the largest multimodal foundation model i
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
08:00am, Wednesday, 23'rd Apr 2025
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced multi-year, strategic collabora
AstraZeneca CEO says Europe must protect its health sovereignty, is falling behind on pharma investments
07:28am, Wednesday, 23'rd Apr 2025
AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that Europe has stepped up its defence spending and now must protect its health sovereignty amid a shifting world order.
Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know
07:20pm, Tuesday, 22'nd Apr 2025
The latest trading day saw Astrazeneca (AZN) settling at $67.87, representing a +1.45% change from its previous close.
AstraZeneca rejoins leading U.S. drug lobby group after two-year absence
04:10pm, Tuesday, 22'nd Apr 2025
AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and Manufacturers of America (PhRMA) said on Tuesday.
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
AstraZeneca reports best trial results in a decade for metastatic breast cancer treatment
02:39am, Tuesday, 22'nd Apr 2025
AstraZeneca PLC (LSE:AZN) reported notable progress in ongoing trials of patients with metastatic breast cancer using a combination of drugs, Enhertu and pertuzumab. Enhertu, jointly developed by t
Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings?
09:25am, Monday, 21'st Apr 2025
AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, are expected to have driven the company's top line.
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
09:00am, Monday, 21'st Apr 2025
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
Selling America, Buying Europe - My Picks
09:15am, Sunday, 20'th Apr 2025
After years of strong returns, amidst the tariff-induced uncertainty, I am rotating towards European-based equities. US economy is facing mounting pressures, via weakening consumer demand, reduced CAP
European pharma companies issue demands to stay in EU ahead of expected US tariffs
02:33pm, Tuesday, 15'th Apr 2025
Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to maintain operations in the EU despite threatened U.S. tariffs on imports, inclu
Trump Says Pharmaceutical Tariffs Coming in Near Future
02:03pm, Monday, 14'th Apr 2025
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with repo
Trump says US pharma tariffs coming in not-too-distant future
12:26pm, Monday, 14'th Apr 2025
U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.
